| Name | Title | Contact Details |
|---|---|---|
Peter Graham |
Chief Legal Officer | Profile |
Wendy Williams |
Head of U.S. Legal | Profile |
Maria Galdos |
Senior Director, Healthcare Compliance | Profile |
Rogan Nunn |
Head of US Legal | Profile |
AnHeart is a clinical stage global biopharmaceutical company developing novel precision oncology therapeutics. Its lead candidate, taletrectinib, is a next-generation ROS1 and NTRK inhibitor currently in Phase 2 trials in first and second-line non-small cell lung cancer (NSCLC). AnHeart is developing a broad pipeline of next-generation precision oncology therapeutics in areas of high unmet medical need.
University Technologies International is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
arizonia infectious disease society is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IQuum is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.